The activation of the Wnt signalling pathway is implicated in tumour growth and the poor prognosis of triple-negative breast cancer that lacks the expression of HER2, estrogen, and progesterone receptors. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.